Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.

Naeim, Arash; Friedman, Lyssa; Whitlock, Kimberly B; Pasta, David J; Elkin, Eric P; Lubeck, Deborah P; Viswanathan, Hema N; Glaspy, John

Naeim, Arash; Friedman, Lyssa; Whitlock, Kimberly B; Pasta, David J; Elkin, Eric P; Lubeck, Deborah P; Viswanathan, Hema N; Glaspy, John.

Afiliación

Naeim A; University of California Los Angeles, Los Angeles; McKesson Specialty Care Solutions, San Rafael; ICON Clinical Research, Lifecycle Sciences Group, San Francisco; and Amgen, Thousand Oaks, CA.

J Oncol Pract ; 5(5): 236-43, 2009 Sep.

Article en En | MEDLINE | ID: mdl-20856735

ABSTRACT

ABSTRACT

Use of erythropoiesis-stimulating agents in the treatment of myelosuppresive chemotherapy-induced anemia has been shown to increase hemoglobin levels and reduce the need for transfusions in patients with cancer.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Oncol Pract Año: 2009 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google